Sanofi, Translate Bio Post Positive Early Covid-19 Vaccine Results; Plan Human TestingInvestors Business Daily • 10/15/20
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studiesGlobeNewsWire • 10/15/20
Translate Bio Highlights mRNA Platform Potential for the Treatment of Cystic Fibrosis (CF) at the 34th Annual North American Cystic Fibrosis ConferenceGlobeNewsWire • 10/07/20
Translate Bio Resumes Enrollment and Dosing in Phase 1/2 Clinical Trial of MRT5005 in Cystic FibrosisGlobeNewsWire • 09/08/20
Translate Bio Announces Second Quarter 2020 Financial Results and Reviews Recent ProgressGlobeNewsWire • 08/06/20
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Translate Bio, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 07/31/20
Has Translate Bio (TBIO) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 07/30/20
Translate Bio, Inc. (TBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 07/22/20
Translate Bio Announces Closing of Expanded Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for All Infectious DiseasesGlobeNewsWire • 07/20/20
Is Translate Bio (TBIO) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 07/14/20
Are Options Traders Betting on a Big Move in Translate Bio (TBIO) Stock?Zacks Investment Research • 06/29/20
Sanofi Accelerates Coronavirus Vaccine Timeline, Says Approval Could Come In First Half Of 2021Benzinga • 06/23/20